Table 2.
Patients’ characterization.
| A | |||
| SEX | N (%) | MEAN AGE (Range) ± SD | |
| Males | 46 (62.2%) | 62 (21–89) ± 17.4 | |
| Females | 28 (37.8%) | 60 (29–87) ± 17.9 | |
| B | |||
| All Patients Positive to the Molecular NasoPharyngeal Swab | |||
| n | % | ||
| T °C at NP swab | <37 °C | 54 | 73 |
| >37 °C | 20 | 27 | |
| T °C at Ocular swab | <37 °C | 55 | 74.3 |
| >37 °C | 19 | 25.7 | |
| Respiratory Symptoms | none | 3 | 4.1 |
| mild | 33 | 44.6 | |
| severe | 32 | 43.2 | |
| critical | 6 | 8.1 | |
| Evidence of lung involvement by CT scan | negative | 14 | 19 |
| positive | 60 | 81 | |
| Ocular symptoms | none | 39 | 52.7 |
| mild/moderate | 28 | 37.8 | |
| severe | 7 | 9.5 | |
| PCR positive ocular swab | 3 | 4 | |